DAFTAR PUSTAKA BARU

.
1. Suarjana I. Artritis reumatoid. In : Setiati S, Alwi I, Setyohadi B., Syam AF, Sudoyo
AW, Simadibrata M, editors. Buku Ajar Ilmu Penyakit Dalam Jilid 3, 6th ed. Jakarta:
Internal publishing; 2014: p3130-49.
2. Cush J, Kavanaugh A, Stein CM. Rheumatology Diagnosis & Therappeutics. 2th ed.
Philadelphia: Lippincott Williams & Wilkins; 2005. p.323-333.
3. Silman AJ, Hochberg MC. Descriptive epidemiology of Rematoid arthritis. Dalam:
Hochberg MC,
4. Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds). Rematoid Arthritis. Mosby:
Philadelphia. 2009; 15-224. Tobon GJ, Youinou P, Saraux A. The environment,
5. Gibofsky, 2012, Overview of Epidemiology, Pathophysiology, and Diagnosis of
Rheumatoid Arthritis, The American Journal of Managed Care, VOL. 18, No. 13, pp
:295-302.
6. Blumental, 2012, Rheumatoid Arthritis And The Incidence Of Influenza And Influenza-
Related Complications: A Retrospective Cohort Study BMC Musculoskeletal Disorders
2012, 13:158, 2-10.
7. Arthritis Foundation, 2015, Arthritis Foundation Scientific Strategy 2015-2020,
http://www.arthritis.org /Documents/arthritis-foundationscientific-strategy.pdf
8. Choy, E., 2012, Understanding the dynamics: pathways involved in the pathogenesis
of rheumatoid arthritis, Rheumatology, 2012 ;51:v3-v11. doi:10.1093
/rheumatology/kes113.
9. Nainggolan, O. 2009. Prevalensi dan Determinan Penyakit Rheumatik di Indonesia.
Majalah Kedokteran Indonesia 59: 587-594
10. Sokka T, B. Abelson, & T. Pincus. 2008. Mortality in Rematoid Arthitis. Clin Exp
Rheumatol. 26: 35-36
11. Yazici, Y & Simsek I. 2005. Traetment Options for Rhematoid Arthritis Beyond TNF-
Alpha Inhibitors. Expert Rev Clin Phamrcol. 3: 663- 666.
12. Aletaha D, Neogi T, Silman A J, Funovits J, Felson DT, Bingham CO, et al. 2010
Rheumatoid Arthritis Classification Criteria. American College of Rheumatology.
Arthritis Rheum. 2010;62(9):2569-81.
13. Arnandi, Suryadhana NG, IK Yoga . In : Setiati S, Alwi I, Setyohadi B., Syam AF,
Sudoyo AW, Simadibrata M, editors. Buku Ajar Ilmu Penyakit Dalam Jilid 3, 6th ed.
Jakarta: Internal publishing; 2014: p 3105-3114.
14. Snir O, Widhe M, Hermansoon M, Spee C, Linberg J, Hensen S, et al. (2010).
Antibodies to several citrunillated antigen are enriched in the joints of Rheumatoid.
Arthritis Patients. Arthithis & Rheum; 62 (1): 44-52.
15. Wyness SP, La’ulu SL, Hunsaker JJH, Tebo AE, Robert WL (2010). Performance
characteristics of three random access cyclic citrunillated peptide antibody assay. Clinic
Chem Acta; 411 : 428-432.
16. De Rycke L, Peene I, Hoffman IE et al. Rheumatoid factor and anticitrullinated protein
antibodies in rheumatoid arthritis: diagnostic value, associations with radiological
progression rate, and extra-articular manifestations. Ann Rheum Dis 2004;63:1587_93.
17. Soos L, Szekanecz Z, Szabo Z et al. Clinical evaluation of anti-mutated citrullinated
vimentin by ELISA in rheumatoid arthritis. J Rheumatol 2007;34:1658_63.
18. Dejaco C, Klotz W, Larcher H, Duftner C, Schirmer M, Herold M. Diagnostic value of
antibodies against a modified citrullinated vimentin in rheumatoid arthritis. Arthritis
Res Ther 2006;8:R119.
19. El Shazly, Hussein SA, Raslan ZH, Elgogary AA, Anti-Mutated Citrullinated Vimentin
antibodies in Rheumatoid atritis patients: relation to disease activity and
manifestations. At The Egyptian Rheumatologist, 2013.
20. Kumar M, Chawla S, Jain A, Comparative Study of amti-mutated citruliinated vimentin
anti-clycic citrullinated peptides, and rheumatoid factor predictability in the diagnosis
of rheumatoid arthritis. Internasional Jurnal of Research in Medical Sciences, August
2015;3 (8): 1949-1952.
21. Suarjana I. Artritis reumatoid. In : Setiati S, Alwi I, Setyohadi B., Syam AF, Sudoyo
AW, Simadibrata M, editors. Buku Ajar Ilmu Penyakit Dalam Jilid 3, 6 th ed. Jakarta:
Internal publishing; 2014: p3130-49.
22. Gibofsky, 2012, Overview of Epidemiology, Pathophysiology, and Diagnosis of
Rheumatoid Arthritis, The American Journal of Managed Care, VOL. 18, No. 13, pp
:295-302
23. Blumental, 2012, Rheumatoid Arthritis And The Incidence Of Influenza And Influenza-
Related Complications: A Retrospective Cohort Study BMC Musculoskeletal Disorders
2012, 13:158, 2-10.
24. Ming Dai, 2003, Prevalence of Rheumatic Symptoms, Rheumatoid Arthritis,
Ankylosing Spondylitis, and Gout in Shanghai, China: A COPCORD Study, The
Journal of Rheumatology, 2245-2251.
25. Carter, Michael A. Arthritis Reumatoid. Dalam: Price, SA and Wilson LM, editors.
Patofisiologi Edisi 6 Volume 2. Jakarta: EGC; 2005.hal.1385-91.
26. Muratake T, Hayashi S, Ichikawa T. Structural organization and chromosomal
assignment of the human 14-3-3 eta Chain Gene (YWHAH). The Journal Mol.
Neurobiol. 1996: 63-69.
27. Singh JA, Saag KG, Bridges SL Jr. Evidence-based guideline: ACR made 10 strong
treatment recommendations for RA, but high-quality evidence was sparse. American
College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis
Rheumatol. 2016; 68: 1-26.
28. Van Schaardenburg D, Maksymowych WP, Boers M, Turk S, Marotta A. 14-3-3ε is an
independent predictor of radiographic changes in early RA and higher titres inform a
higher likelihood of joint damage progression. Ann Rheum Dis. 2014: 0244.
29. Maksymowych WP, Marotta A. 14-3-3ε, a novel mediator upregulated by TNFα,
reflects clinical response to anti-TNF therapy. Arthritis Rheum. 2011 :428.
30. Eustice, C., 2007, Everything Health Guide To Arthritis, Adam Media, Avon, pp. 53.
31. Nerl, 2012, Accutex Rheumatoid Factor (RF) Latwx Test, Nerl Diagnostics LLC,
Washington DC.
32. Swannalai , P.,2011, The Fine Specificity of IgM Anti-citrullinated Protein Antibodies
(ACPA) is Different From That Of IgG ACPA, Biomed Central, Netherland.
33. Langguth ,D ., 2006 , Antibodies to Cyclic Citrullinated Peptides: HowTthey Assist In
The Diagnosis of Rheumatoid Arthritis , Autralian Precriber , Australia.
34. Bose , N, MD ., 2012 , Should I Order An Anti-CCP Antibody Tes to Diagnose
Rheumatoid Arthritis? , Cleveland Clinic Journal Of Medicine, Ohio.
35. Egerer, K., 2009, The Serological Diagnosis of Rheumatoid Arthritis, Deutsches
Ärzteblatt International, Germani.
36. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham Co, et al. 2010.
Rheumatoid Arthritis Classification Criteria. An American College of
Rheumatology/European League against Rheumatism Collaborative Initiative.
Arthritis Rheumatism Collaborative Initiative. Arthritis & Rheumatism; 62 (9); 2569-
81.
37. Isaacs J, Olech E, Tak P et al. 2009. Autoantibody-positive rheumatoid arthritis patients
have enhanced clinical response to rituximab when compare with seronegative patients.
Ann Rheum Dis; 68:422.
38. Marc, 2009, Hypersensitivity Reactions and Methods of Detection, Neuroscience, vol
372, pp.1-4.
39. Gmabar
40. Mclnnes, 2011, The Pathogenesis of Rheumatoid Arthritis, N Engl j med, vol 365, pp :
2205-2219.
41. Klareskog, 2006, A New Model for an Etiology of Rheumatoid Arthritis Smoking May
Trigger HLA–DR (Shared Epitope)–Restricted Immune Reactions to Autoantigens
Modified by Citrullinationm, American College of Rheumatology, vol 54 no 1 pp : 38-
46.
42. Scott, 2010, Rheumatoid arthritis, Lancet, vol 376, 1094-1108.
43. Ursum, 2010, Different Properties Of ACPA and Igm-RF Derived From A Large
Dataset: Further Evidence Of Two Distinct Autoantibody Systems, Rhinitis Research
and Therapy, 11, no3, pp: 1-6.

44. Marc, 2009, Hypersensitivity Reactions and Methods of Detection, Neuroscience, vol
372, pp.1-4.
45. Gambar 1,2,3,
46. Mclnnes, 2011, The Pathogenesis of Rheumatoid Arthritis, N Engl j med, vol 365, pp :
2205-2219.
47. Klareskog, 2009, A New Model for an Etiology of Rheumatoid Arthritis Smoking May
Trigger HLA–DR (Shared Epitope)–Restricted Immune Reactions to Autoantigens
Modified by Citrullinationm, American College of Rheumatology, vol 54 no 1 pp : 38-
46.
48. Scott, 2010, Rheumatoid arthritis, Lancet, vol 376, 1094-1108.
49. Ursum, 2010, Different Properties Of ACPA and Igm-RF Derived From A Large
Dataset: Further Evidence Of Two Distinct Autoantibody Systems, Rhinitis Research
and Therapy, 11, no3, pp: 1-6.
50. Bowes |, Barton A. Recent advances in the genetics of RA susceptibility. Rheumatology
2008 47 (4):399 -402.
51. Firestein GS. Etiology and pathogenesis of rheumatoid artfuitis. In: Ruddy S, Harris
ED, Sledge CB, Kelley WN, eds. Kelley's Textbook of rheumatology. 7th ed.
Philadelphia: W.B. Saunders, 2005 :99 6 -10 42.
52. Turesson C, Matteson EL. Genetics of rheumatoid arthritis. Mayo Clin Proc
2006;81(1):94-\01.
53. Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen )A.
Matemal-Fetal Disparity in HLA Class II Alloantigens and the Pregnancy-Induced
Amelioration of Rheumatoid Arthdtis. N Engl J Med1993;329:466-71.
54. Firestein GS. Etiology and pathogenesis of rheumatoid artfuitis. In: Ruddy S, Harris
ED, Sledge CB, Kelley WN, eds. Kelley's Textbook of rheumatology. 7th ed.
Philadelphia: W.B. Saunders, 2005 :99 6 -10 42.
55. Harris ED. Clinical features of rheumatoid arthritis. ln: Ruddy. Harris ED, Sledge CB,
Kelley WN, eds. Kelley's Textbook of rheumatology. 7th ed. Philadelphia: WB
Saunders,2005:1043-78.
56. Mikuls T& Cerhan J& Criswell LA, Merlino L, Mudano AS, Burma M, et aI. Coffee,
tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa
Women's. Health Study. Arthritis Rheum 2002;46:83-91.
57. Kent PD and Matteson EL, editors. Clinical Feature and Differential Diagnosis. In:
St.Clair EW, Pisetsky DS, and haynes BF, editors. Rheumatoid Arthritis 1 st ed. New
York: Lippincott Williams & Wilkins; 2004.p.11-23
58. Mettler , Fred A. Essentials of Radiology 2nd ed. New York: Elsevier Saunders;
2004.p.310-1.
59. Cothran Jr RL and Matinez S, editors. Radiographic Findings. In: St.Clair EW, Pisetsky
DS, and haynes BF, editors. Rheumatoid Arthritis 1st ed. New York: Lippincott
Williams & Wilkins; 2004.p.80-9
60. Lipsky, Peter E. Rheumatoid Arthritis. In: Kasper LK, Fauci AS, Longo DL, Braunwald
E, Hauser SL, and Jameson JL, editors. Harrison’s Principles of Internal Medicine 16th
ed. New York: McGraw-Hill; 2015.p.1968-76.
61. Carter, Michael A. Arthritis Reumatoid. Dalam: Price, SA and Wilson LM, editors.
Patofisiologi Edisi 6 Volume 2. Jakarta: EGC; 2005.hal.1385-91.
1. Muratake T, Hayashi S, Ichikawa T. Structural organization and chromosomal
assignment of the human 14-3-3 eta Chain Gene (YWHAH). The Journal Mol.
Neurobiol. 1996: 63-69.
2. Singh JA, Saag KG, Bridges SL Jr. Evidence-based guideline: ACR made 10 strong
treatment recommendations for RA, but high-quality evidence was sparse. American
College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis
Rheumatol. 2016; 68: 1-26.
3. Van Schaardenburg D, Maksymowych WP, Boers M, Turk S, Marotta A. 14-3-3ε is an
independent predictor of radiographic changes in early RA and higher titres inform a
higher likelihood of joint damage progression. Ann Rheum Dis. 2014: 0244.
4. Maksymowych WP, Marotta A. 14-3-3ε, a novel mediator upregulated by TNFα,
reflects clinical response to anti-TNF therapy. Arthritis Rheum. 2011 :428.
5. Eustice, C., 2007, Everything Health Guide To Arthritis, Adam Media, Avon, pp. 53.
6. Nerl, 2012, Accutex Rheumatoid Factor (RF) Latwx Test, Nerl Diagnostics LLC,
Washington DC.
7. Swannalai , P.,2011, The Fine Specificity of IgM Anti-citrullinated Protein Antibodies
(ACPA) is Different From That Of IgG ACPA, Biomed Central, Netherland.
8. Langguth ,D ., 2006 , Antibodies to Cyclic Citrullinated Peptides: HowTthey Assist In
The Diagnosis of Rheumatoid Arthritis , Autralian Precriber , Australia.
9. Bose , N, MD ., 2012 , Should I Order An Anti-CCP Antibody Tes to Diagnose
Rheumatoid Arthritis? , Cleveland Clinic Journal Of Medicine, Ohio.
10. Egerer, K., 2009, The Serological Diagnosis of Rheumatoid Arthritis, Deutsches
Ärzteblatt International, Germani.
11. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham Co, et al. 2010.
Rheumatoid Arthritis Classification Criteria. An American College of
Rheumatology/European League against Rheumatism Collaborative Initiative.
Arthritis Rheumatism Collaborative Initiative. Arthritis & Rheumatism; 62 (9); 2569-
81.
12. Isaacs J, Olech E, Tak P et al. 2009. Autoantibody-positive rheumatoid arthritis patients
have enhanced clinical response to rituximab when compare with seronegative patients.
Ann Rheum Dis; 68:422.
 13. Marc, 2009, Hypersensitivity Reactions and Methods of Detection, Neuroscience, vol
372, pp.1-4.
14. Gmabar
15. Mclnnes, 2011, The Pathogenesis of Rheumatoid Arthritis, N Engl j med, vol 365, pp :
2205-2219.
16. Klareskog, 2006, A New Model for an Etiology of Rheumatoid Arthritis Smoking May
Trigger HLA–DR (Shared Epitope)–Restricted Immune Reactions to Autoantigens
Modified by Citrullinationm, American College of Rheumatology, vol 54 no 1 pp : 38-
46.
17. Scott, 2010, Rheumatoid arthritis, Lancet, vol 376, 1094-1108.
18. Ursum, 2010, Different Properties Of ACPA and Igm-RF Derived From A Large
Dataset: Further Evidence Of Two Distinct Autoantibody Systems, Rhinitis Research
and Therapy, 11, no3, pp: 1-6.
19. Matsuo K, Xiang Y, Nakamura H et al. Identification of novel citrullinated autoantigens
of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res Ther
2006;8:R175.
20. Tilleman K, Van Steendam K, Cantaert T, De Keyser F,Elewaut D, Deforce D.
Synovial detection and autoantibody reactivity of processed citrullinated isoforms of
vimentin in inflammatory arthritides. Rheumatology 2008;47:597_604.
21. Kinloch A, Tatzer V, Wait R et al. Identification of citrullinated alpha-enolase as a
candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther 2005;7:R1421_9.
22. Kinloch A, Lundberg K, Wait R et al. Synovial fluid is a site of citrullination of
autoantigens in inflammatory arthritis. Arthritis Rheum 2008;58:2287_95.
23. Yoshida M, Tsuji M, Kurosaka D et al. Autoimmunity to citrullinated type II collagen
in rheumatoid arthritis. Mod Rheumatol 2006;16:276_81.
24. Masson-Bessiere C, Sebbag M, Durieux J et al. In the rheumatoid pannus, anti-filaggrin
autoantibodies are produced by local plasma cells and constitute a higher proportion of
IgG than in synovial fluid and serum. Clin Exp Immunol 2000;119:544_52.
25. Reparon-Schuijt CC, van Esch WJ, van Kooten C et al. Secretion of anti-citrulline-
containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum
2001;44:41_7.
26. Gambar
27. Durrant LA, Archer CW, Benjamin M, Ralphs JR. Organisation of the chondrocyte
cytoskeleton and its response to changing mechanical conditions in organ culture. J
Anat 1999;194:343_53.
___________________________________________________________________________

De Rycke L, Peene I, Hoffman IE et al. Rheumatoid factor and anticitrullinated protein

antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression
rate, and extra-articular manifestations. Ann Rheum Dis 2004;63:1587_93.

Soos L, Szekanecz Z, Szabo Z et al. Clinical evaluation of anti-mutated citrullinated vimentin

by ELISA in rheumatoid arthritis. J Rheumatol 2007;34:1658_63.

Dejaco C, Klotz W, Larcher H, Duftner C, Schirmer M, Herold M. Diagnostic value of

antibodies against a modified citrullinated vimentin in rheumatoid arthritis. Arthritis Res Ther
2006;8:R119.
Rodriguez-Mahou M, Lopez-Longo FJ, Sanchez-Ramon S et al. Association of anti-cyclic
citrullinated peptide and anti-Sa/citrullinated vimentin autoantibodies in rheumatoid arthritis.
Arthritis Rheum 2006;55:657_61.

Sghiri R, Bouajina E, Bargaoui D et al. Value of antimutated citrullinated vimentin antibodies

in diagnosing rheumatoid arthritis. Rheumatol Int 2008;29:59_62.

Goldbach-Mansky R, Lee J, McCoy A et al. Rheumatoid arthritis associated autoantibodies in

patients with synovitis of recent onset. Arthritis Res 2000; 2:236_43.

Mathsson L, Mullazehi M, Wick MC et al. Antibodies against citrullinated vimentin in

rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future
radiographic progression as compared with antibodies against cyclic citrullinated peptides.
Arthritis Rheum 2008;58:36_45.

Raza K, Mathsson L, Buckley CD, Filer A, Ronnelid J. Antimodified citrullinated vimentin

(MCV) antibodies in patients with very early synovitis. Ann Rheum Dis 2010;69:627.

Poulsom H, Charles P. Antibodies to citrullinated vimentin are a specific and sensitive marker
for the diagnosis of rheumatoid arthritis. Clin Rrev Allerg Immu 2008;34:4_10.